Literature DB >> 17149999

BETA2/NeuroD protein transduction requires cell surface heparan sulfate proteoglycans.

Hirofumi Noguchi1, Michiko Ueda, Shinichi Matsumoto, Naoya Kobayashi, Shuji Hayashi.   

Abstract

BETA2/NeuroD protein is important for regulating insulin gene transcription and for the terminal differentiation of islet cells, including insulin- and glucagon-producing cells. We reported that BETA2/NeuroD protein can permeate several cell types, including pancreatic islets, because of an arginine- and lysine-rich protein transduction domain (PTD) sequence in its structure. Here we provide genetic and biochemical evidence that cell membrane heparan sulfate proteoglycans are involved in extracellular BETA2/NeuroD internalization. We tested whether soluble glycosaminoglycans (GAGs) could inhibit BETA2/NeuroD internalization. Heparin almost completely prevented BETA2/NeuroD entry, whereas chondroitin sulfate A, B, and C caused only limited inhibition. Moreover, treatment with heparinase III impaired BETA2/NeuroD internalization, whereas treatment with chondroitinase ABC, or with chondroitinase AC, was completely ineffective in inhibiting BETA2/NeuroD internalization. We also examined various mutant cell lines originating from CHOK1 cells and defective in GAG biosynthesis. The observation using mutant cell lines supports the notion that the selective sulfation of heparan sulfate is an important determinant for NeuroD/heparan sulfate recognition. These data indicate that cell surface heparan sulfate proteoglycans are required for BETA2/NeuroD internalization and that BETA2/NeuroD protein transduction could be a safe and valuable strategy for enhancing insulin gene transcription without requiring gene transfer technology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17149999     DOI: 10.1089/hum.2006.118

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  8 in total

1.  Inhibition of heparanase protects against pancreatic beta cell death in streptozotocin-induced diabetic mice via reducing intra-islet inflammatory cell infiltration.

Authors:  Wen-Yu Song; Xiao-Han Jiang; Ying Ding; Yan Wang; Ming-Xuan Zhou; Yun Xia; Chen-Yu Zhang; Chong-Chong Yin; Chen Qiu; Kai Li; Peng Sun; Xiao Han
Journal:  Br J Pharmacol       Date:  2020-08-19       Impact factor: 8.739

2.  Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.

Authors:  Jennifer Y C Cheng; John Whitelock; Laura Poole-Warren
Journal:  Histochem Cell Biol       Date:  2012-08-08       Impact factor: 4.304

3.  Recent advances in stem cell research for the treatment of diabetes.

Authors:  Hirofumi Noguchi
Journal:  World J Stem Cells       Date:  2009-12-31       Impact factor: 5.326

4.  Genome-wide identification, classification, and functional analysis of the basic helix-loop-helix transcription factors in the cattle, Bos Taurus.

Authors:  Fengmei Li; Wuyi Liu
Journal:  Mamm Genome       Date:  2017-03-15       Impact factor: 2.957

5.  Pancreatic islet transplantation.

Authors:  Hirofumi Noguchi
Journal:  World J Gastrointest Surg       Date:  2009-11-30

6.  Hyaluronan and hyaluronan binding proteins are normal components of mouse pancreatic islets and are differentially expressed by islet endocrine cell types.

Authors:  Rebecca L Hull; Pamela Y Johnson; Kathleen R Braun; Anthony J Day; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2012-07-21       Impact factor: 2.479

7.  Module M1 of zebrafish neuroglobin acts as a structural and functional protein building block for a cell-membrane-penetrating activity.

Authors:  Seiji Watanabe; Keisuke Wakasugi
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

8.  RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice.

Authors:  Hirofumi Noguchi; Koji Sugimoto; Chika Miyagi-Shiohira; Yoshiki Nakashima; Naoya Kobayashi; Issei Saitoh; Masami Watanabe; Yasufumi Noguchi
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.